LifeStance Health Group, Inc.

NasdaqGS:LFST Stock Report

Market Cap: US$2.4b

LifeStance Health Group Future Growth

Future criteria checks 1/6

LifeStance Health Group is forecast to grow earnings and revenue by 55.8% and 12.5% per annum respectively. EPS is expected to grow by 51.2% per annum. Return on equity is forecast to be -3.7% in 3 years.

Key information

55.8%

Earnings growth rate

51.2%

EPS growth rate

Healthcare earnings growth19.3%
Revenue growth rate12.5%
Future return on equity-3.7%
Analyst coverage

Good

Last updated22 Aug 2024

Recent future growth updates

Recent updates

Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt

Sep 02
Here's Why LifeStance Health Group (NASDAQ:LFST) Can Afford Some Debt

LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price

Aug 11
LifeStance Health Group, Inc. (NASDAQ:LFST) Just Reported Earnings, And Analysts Cut Their Target Price

LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price

Jul 15
LifeStance Health Group, Inc.'s (NASDAQ:LFST) Intrinsic Value Is Potentially 63% Above Its Share Price

With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For

Jun 07
With LifeStance Health Group, Inc. (NASDAQ:LFST) It Looks Like You'll Get What You Pay For

LifeStance: Selloff Opens Buying Opportunity Thanks To Price/Value Dislocation

May 23

LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results

May 12
LifeStance Health Group, Inc. (NASDAQ:LFST) Analysts Are Pretty Bullish On The Stock After Recent Results

Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching

May 06
Why LifeStance Health Group, Inc. (NASDAQ:LFST) Could Be Worth Watching

Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)

Mar 23
Calculating The Intrinsic Value Of LifeStance Health Group, Inc. (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50

Mar 02
LifeStance Health Group, Inc. (NASDAQ:LFST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.50

LifeStance Q4 Earnings Review: Monetizing Mental Health Virtually Is Problematic

Feb 29

Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?

Feb 28
Does LifeStance Health Group (NASDAQ:LFST) Have A Healthy Balance Sheet?

LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable

Jan 23
LifeStance Health Group, Inc.'s (NASDAQ:LFST) P/S Still Appears To Be Reasonable

What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?

Jul 08
What Is LifeStance Health Group, Inc.'s (NASDAQ:LFST) Share Price Doing?

Is LifeStance Health Group, Inc. (NASDAQ:LFST) Expensive For A Reason? A Look At Its Intrinsic Value

May 09
Is LifeStance Health Group, Inc. (NASDAQ:LFST) Expensive For A Reason? A Look At Its Intrinsic Value

LifeStance Health appoints new key person

Sep 08

Is LifeStance Health Group, Inc. (NASDAQ:LFST) Trading At A 48% Discount?

Sep 05
Is LifeStance Health Group, Inc. (NASDAQ:LFST) Trading At A 48% Discount?

Earnings and Revenue Growth Forecasts

NasdaqGS:LFST - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,576-27591194
12/31/20251,386-6055987
12/31/20241,223-894367
6/30/20241,156-151-1814N/A
3/31/20241,104-173-69-31N/A
12/31/20231,056-186-57-17N/A
9/30/20231,004-188-372N/A
6/30/2023959-164-1133N/A
3/31/2023909-187-1742N/A
12/31/2022860-216-2653N/A
9/30/2022820-277-6048N/A
6/30/2022776-360-8928N/A
3/31/2022727-361-1093N/A
12/31/2021668-344-859N/A
9/30/2021596-515-83-17N/A
6/30/2021524-397-448N/A
3/31/2021447-331-42-1N/A
12/31/2020377-286-47-9N/A
12/31/2019213-59317N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LFST is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: LFST is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: LFST is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: LFST's revenue (12.5% per year) is forecast to grow faster than the US market (8.7% per year).

High Growth Revenue: LFST's revenue (12.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LFST is forecast to be unprofitable in 3 years.


Discover growth companies